World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
9791
World Ranking
4416
National Ranking
2005

Alan L. Schmaljohn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alan L. Schmaljohn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 72 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alan L. Schmaljohn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alan L. Schmaljohn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Alan L. Schmaljohn is affiliated with the University of Maryland, Baltimore in the United States. Their professional work is connected to this institution, reflecting an academic role and involvement in research activities there.

Although detailed records of recent papers, co-authors, and publication venues are not available, the scientist's career profile indicates an established presence in academic research within their institutional framework.

There is no specific information on main fields or subfields of study, nor on principal topics of research. Similarly, records do not include book publications or awards received, which limits further elaboration on the subject's research trajectory and scholarly contributions.

The absence of recent paper listings or data on frequent collaboration partners means there is no detailed description of recent scientific outputs or ongoing research projects. However, the association with a well-known university suggests engagement with current research trends and academic activities typical of faculty members in such institutions.

The lack of information on the scientist's main topics of work or subfields could indicate either a broad scope of research interests or limitations in publicly available data. This profile reflects only verifiable details without assumptions about areas of specialization or research impact.

Best Publications

  • Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management

    Luciana Borio;Thomas Inglesby;C. J. Peters;Alan L. Schmaljohn

  • Epitopes involved in antibody-mediated protection from Ebola virus

    Julie A. Wilson;Michael Hevey;Russell Bakken;Shawn Guest

  • Lipid Raft Microdomains A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses

    Sina Bavari;Catharine M. Bosio;Elizabeth Wiegand;Gordon Ruthel

  • Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates

    Michael Hevey;Diane Negley;Peter Pushko;Jonathan Smith

  • Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation

    Catharine M. Bosio;M. Javad Aman;Case Grogan;Robert Hogan

  • Smallpox DNA Vaccine Protects Nonhuman Primates against Lethal Monkeypox

    J. W. Hooper;E. Thompson;C. Wilhelmsen;M. Zimmerman

  • Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

    A. L. Schmaljohn;E. D. Johnson;J. M. Dalrymple;G. A. Cole

  • Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order

    Connie S Schmaljohn;Alan L Schmaljohn;Joel M Dalrymple

  • Ebola virus-like particles protect from lethal Ebola virus infection

    Kelly L. Warfield;Catharine M. Bosio;Brent C. Welcher;Emily M. Deal

  • Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

    Connie S. Schmaljohn;Yong-Kyu Chu;Alan L. Schmaljohn;Joel M. Dalrymple

  • Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

    Peter Pushko;Mike Bray;George V Ludwig;Michael Parker

  • Folate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses

    Stephen Y. Chan;Cyril J. Empig;Frank J. Welte;Roberto F. Speck

  • Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies

    Jiro Arikawa;Alan L. Schmaljohn;Joel M. Dalrymple;Connie S. Schmaljohn

  • DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

    J.W. Hooper;D.M. Custer;C.S. Schmaljohn;A.L. Schmaljohn

  • DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.

    Lorna Vanderzanden;Mike Bray;Deborah Fuller;Tim Roberts

  • The evolving field of biodefence: therapeutic developments and diagnostics

    James C. Burnett;Erik A. Henchal;Alan L. Schmaljohn;Sina Bavari

  • How Ebola and Marburg viruses battle the immune system

    Mansour Mohamadzadeh;Mansour Mohamadzadeh;Lieping Chen;Alan L. Schmaljohn

  • Complete nucleotide sequences of the M and S segments of two hantavirus isolates from California: evidence for reassortment in nature among viruses related to hantavirus pulmonary syndrome.

    Dexin Li;Alan L. Schmaljohn;Kevin Anderson;Connie S. Schmaljohn

  • Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

    Dana L. Swenson;Kelly L. Warfield;Diane L. Negley;Alan Schmaljohn

  • Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.

    Michael Hevey;Diane Negley;Joan Geisbert;Peter Jahrling

Frequent Co-Authors

Connie S. Schmaljohn
Connie S. Schmaljohn National Institutes of Health
Sina Bavari
Sina Bavari United States Army Medical Research Institute of Infectious Diseases
M. Javad Aman
M. Javad Aman Integrated BioTherapeutics (United States)
Jay W. Hooper
Jay W. Hooper United States Department of the Army
Joel M. Dalrymple
Joel M. Dalrymple United States Department of the Army
Peter B. Jahrling
Peter B. Jahrling National Institutes of Health
Mansour Mohamadzadeh
Mansour Mohamadzadeh The University of Texas Health Science Center at San Antonio
Kelly L. Warfield
Kelly L. Warfield United States Department of the Army
Jonathan F. Smith
Jonathan F. Smith Research Triangle Park Foundation
Mike Bray
Mike Bray National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often involves exploring related healthcare fields, especially within nursing and advanced practice degrees. For those interested in mental health alongside immunology, programs like the cheapest pmhnp programs online offer affordable pathways into psychiatric nurse practitioner roles.

Understanding potential earnings is crucial when choosing a career path. Nurse practitioners with a Doctor of Nursing Practice (DNP) degree can benefit from reviewing the dnp salary by state data to make informed decisions about their education and job markets.

Many nurses begin as Family Nurse Practitioners (FNPs) but seek specialized roles. Transitioning through certifications such as described in the fnp to acute care certification guide allows professionals to adapt their expertise to acute care settings, which can intersect with immunology-related patient care.

For students aiming to enter nurse practitioner roles quickly, accelerated programs are an excellent option. The accelerated fnp programs highlight streamlined pathways that help meet workforce demands efficiently.

Best Scientists Citing Alan L. Schmaljohn

Trending Scientists